(Q35194370)

7 August 2017

1 reference

title

Gastrointestinal side effects of drugs (English)

1 reference

7 August 2017

Richard Makins

1

1 reference

7 August 2017

Anne Ballinger

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Drug Safety

7 August 2017

published in

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

421-429

1 reference

Oral manifestations of drug therapy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Orofacial effects of antiretroviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Oral ulcers caused by hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Nicorandil can induce severe oral ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Recalcitrant oral ulcers caused by calcium channel blockers: diagnosis and treatment considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Cinnamon-induced oral erythema multiformelike sensitivity reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Pill-induced esophagitis caused by oral rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Benign stricture of the oesophagus: role of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Esophagitis associated with the use of alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Effect of nifedipine administration (10 mg) on esophageal acid exposure time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Alendronate and naproxen are synergistic for development of gastric ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Drug induced acute pancreatitis: incidence and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.4.421

21 January 2018

Identifiers

DOI

10.1517/14740338.2.4.421

1 reference

7 August 2017

1 reference